The Women Who Are Changing Lives in Life Sciences
“Women belong in all places where decisions are being made..”
– Ruth Bader Ginsburg
The evolution of women from entering the laboratory to the CEO’s chair is a long-fought battle. The result? Women in the life sciences are playing roles that are no longer conventional – fundamentally transforming the industry’s future. Breaking the glass ceiling has never been easy, and we’ve witnessed stellar personalities who have risen beyond limitations, set new benchmarks in life sciences through resilience, innovation, and leadership and continue to do so. TechEela and ClairLabs bring to you the celebration of Women— ’Beyond 8’, commemorating women leaders in the life sciences industry who are redefining leadership in the tech space.
From pioneering groundbreaking innovations to revolutionary treatments to recalibrating governance and spearheading innovation, women have carved their way into the life sciences domain, holding around 25% of senior leadership and board member roles in today’s scenario. We take pride in acknowledging such stellar personalities—their dedication, resilience, and vision fueling scientific advancements and improving patient outcomes worldwide.
Beyond the Horizon—Women Leading the Life Sciences Space:
Featuring
Suneeta Reddy – Managing Director, Apollo Hospitals:
A visionary architect in Indian healthcare, Suneeta Reddy – MD of Apollo Hospitals, has played a pivotal role in transforming Apollo Hospitals into a globally renowned healthcare powerhouse. With her strategic acumen and unwavering commitment to patient care, she has been the driving force behind Apollo’s remarkable expansion—offering world-class medical care to over 150 million people from around 140 countries. Since 1989, her promise to holistic medical services has led to the launch of Apollo Reach Hospitals, a model recognized by the World Bank—making quality healthcare accessible in semi-urban and rural areas.
Her financial expertise in revolutionizing healthcare investments in India, has significantly propelled the healthcare standards of Apollo Hospital globally. She secured India’s first-ever foreign direct investment (FDI) in healthcare, opening the doors for Apollo’s entry into international equity markets through a Global Depository Receipt (GDR) issue.
Under her visionary leadership, Apollo has embraced cutting-edge medical technology, AI-powered diagnostics, and digital healthcare innovations – culminating in the launch of Apollo 24/7 with a singular mission – to make world-class healthcare more accessible. Her commitment to innovation ensures that Apollo Hospitals remains at the forefront of modern medical advancements.
In a defining moment of recognition, Suneeta’s unparalleled guidance and Apollo Hospitals’ unwavering dedication during the COVID-19 crisis earned her the prestigious Economic Times Businesswoman of the Year award. A champion of corporate social responsibility, she continues to extend her influence through numerous health initiatives, most notably supporting underprivileged children battling thalassemia. Her deep-rooted belief in holistic wellness goes beyond advocacy—she embodies the very principles of fitness and balanced living that are integrated into Apollo’s healthcare philosophy, inspiring a culture of well-being.
Pooja Chatrath – Chief Information Officer, Oncquest Laboratories Ltd :
For Pooja Chatrath, the future of diagnostics isn’t just digital—it is a revolution powered by artificial intelligence, keeping patient wellness at the core. As a Chief Information Officer of Oncquest Laboratories, she has been instrumental in leveraging artificial intelligence, big data analytics, and cloud computing. In her leadership tenure, she has facilitated the seamless integration of telepathology and AI-driven diagnostics, ensuring easy accessibility and preciseness of laboratory medicine.
Recognized by ‘CIO Insider India’ as a thought leader, Pooja Chatrath is lazer focused on enhancing diagnostic accuracy and efficiency, spearheading the integration of artificial intelligence, big data analytics, and cloud computing into laboratory medicine. A strong advocate of agile digital transformation, she ensures the adaptability and resilience of organizations in an increasingly competitive landscape. She underlines and emphasizes the need for interoperable healthcare systems, where data-driven insights improve patient outcomes, streamline workflows, and enhance decision-making for clinicians. At her helm in Oncquest Laboratories, they have adopted state-of-the-art solutions revolutionizing pathology services, thereby setting new industry benchmarks in speed, accuracy, and accessibility.
Beyond technology, she is also deeply committed to bridging the gap between research and clinical applications—ensuring that advancements in diagnostics translate into real-world patient benefits.
Lynelle Hoch – President, Cell Therapy Organization, Bristo Myers Squibb :
A trailblazer in regenerative medicine and cell therapy, Lynelle Hoch stands at the forefront of rewiring the future of cancer treatment at Bristol Myers Squibb. She serves as the President of the Cell Therapy Organization, leading a cross-functional team keenly dedicated to the research, development, manufacturing, and commercialization of BMS’ cell therapy portfolio, pushing beyond the boundaries of personalized medicine.
“Cell therapy represents one of the most promising and exciting scientific advancements that will continue to revolutionize the way we approach cancer treatment, and now potentially
B-cell mediated autoimmune disorders.”
– Lynelle Hoch
Lynelle adds that at BMS, the drive to revolutionize patients’ lives through science has fueled their talented teams to push boundaries and advance groundbreaking innovations while humbly acknowledging that they have yet to achieve all milestones in the journey.
With a career span in leading global healthcare for over 25 years, Lynelle’s expertise holds an impressive trajectory across sales, marketing, market access, and general management. Prior to this helm, she served as a General Manager for BMS UK and Ireland, playing a key role in expanding the company’s footprint and accelerating access to life-changing medicines. She has also led the BMS’ global immuno-oncology marketing strategy, laying the foundation for groundbreaking cancer therapies.
An ardent believer of diversity in leadership and talent development—Lynelle continues to make an indelible impact on the life sciences industry. Her contributions to business transformation in the healthcare space remain both profound and far-reaching. Recognizing her unwavering commitment, she has been named among the Top 50 Healthcare Influencers in the U.S. by MM&M week and honored as one of Fierce Pharma’s 2023 Fiercest Women in Life Sciences—a testament to her influence and leadership in shaping the future of cell therapy.
These remarkable women are not just leading organizations in the life sciences space but are also paving the way for future generations of women in science, technology, and healthcare. Their leadership, resilience, and innovation are testaments to the limitless potential of women in life sciences.
This International Women’s Month, as we celebrate their achievements, let us amplify their voices and strive toward a future where women have equal representation in leadership and decision-making roles across industries.
